Coronary artery disease medications
Pro Research Analysisby 
Searched over 200M research papers
Key Medications for Coronary Artery Disease: Antiplatelets, Statins, Beta-Blockers, and More
The main medications used to manage coronary artery disease (CAD) include antiplatelet agents (like aspirin and clopidogrel), statins, beta-blockers, angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers (ARBs), and antianginal drugs. Antiplatelet therapy, especially aspirin, is a cornerstone for both primary and secondary prevention, though its use for primary prevention is now more limited due to bleeding risks 679. Statins are recommended for all patients unless contraindicated, as they help lower cholesterol and reduce cardiovascular risk 17. Beta-blockers are typically the first-line antianginal medication, with calcium channel blockers, nitrates, and ranolazine used as adjuncts or alternatives . In patients with comorbidities like hypertension or diabetes, antihypertensive and antidiabetic medications are also commonly prescribed 27.
Antithrombotic and Antiplatelet Therapy in CAD
Antithrombotic treatment, including antiplatelet agents (aspirin, clopidogrel, and others) and sometimes anticoagulants, is essential in reducing the risk of ischemic events in CAD. Dual antiplatelet therapy (DAPT), combining a thromboxane A2 inhibitor (like aspirin) with a P2Y12 inhibitor, is often used after acute coronary syndromes or percutaneous coronary intervention (PCI) 68. The choice and duration of therapy must balance the benefits of reducing ischemic risk with the increased risk of bleeding . Indobufen, an alternative to aspirin, may be considered in certain low-risk patients or when aspirin is contraindicated, though more research is needed .
Medication Adherence and Its Impact on Outcomes
Good adherence to evidence-based medications—such as beta-blockers, ACE inhibitors/ARBs, antiplatelet drugs, and statins—significantly lowers the risk of all-cause mortality, cardiovascular mortality, and hospitalizations for myocardial infarction in patients with stable CAD 145. High adherence also leads to reduced healthcare costs . However, many patients struggle with long-term medication persistence due to factors like fatalistic beliefs, feeling "cured" after interventions, dislike of taking pills, or concerns about side effects . The relationship with prescribing clinicians and clear communication about the importance of ongoing therapy are critical for improving adherence 310.
Strategies to Improve Medication Adherence in CAD
Educational programs and better communication between healthcare providers and patients can help improve medication adherence, especially among older adults 310. Providing clear information about the benefits and risks of medications, ensuring smooth transitions between hospital and primary care, and addressing patient concerns are all important strategies 310.
Drug Utilization Patterns in Clinical Practice
In real-world settings, most CAD patients receive a combination of drug therapies, with antiplatelet agents being the most commonly prescribed, followed by antihypertensive and antidiabetic medications for those with comorbidities . The majority of drugs are prescribed by their generic names and are included in essential medicines lists, with oral administration being the preferred route .
Conclusion
Medications for coronary artery disease—especially antiplatelet agents, statins, beta-blockers, and ACE inhibitors/ARBs—are essential for reducing cardiovascular risk and improving outcomes. Adherence to these medications is crucial, as it leads to lower mortality, fewer hospitalizations, and reduced healthcare costs. Efforts to improve adherence, including patient education and strong clinician-patient relationships, are key to optimizing the benefits of CAD medications.
Sources and full results
Most relevant research papers on this topic